Perfusion NewswireBlood ManagementThromboelastometry And A Hemostasis Management System are Most Beneficial for Guiding Hemostatic Therapy in Cardiac Surgery Patients with a Euroscore II of ≥1.83%: A Randomized Controlled Two-Step Trial
Thromboelastometry And A Hemostasis Management System are Most Beneficial for Guiding Hemostatic Therapy in Cardiac Surgery Patients with a Euroscore II of ≥1.83%: A Randomized Controlled Two-Step Trial
We evaluated the predictive power of the EuroSCORE, EuroSCORE II and Society of Thoracic Surgeons (STS) score for isolated redo aortic valve replacement.
The current study revealed noninferior myocardial protection and clinical outcomes with DC versus BC in both routine and greater-risk patients undergoing isolated CABG.
